Biogen Inc. has divulged 3-β-hydroxysteroid-δ(8),δ(7)-isomerase (EBP) inhibitors reported to be useful for the treatment of autoimmune disease and multiple sclerosis.

1Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California.

College of Pharmacy and Health Sciences, Western New England University, Springfield, MA (J.A.K., S.E.W., M.K.S., D.R.K.). Institute for Cardiovascular and Metabolic ...